A detailed history of Two Sigma Investments, LP transactions in Galapagos Nv stock. As of the latest transaction made, Two Sigma Investments, LP holds 22,714 shares of GLPG stock, worth $565,351. This represents 0.0% of its overall portfolio holdings.

Number of Shares
22,714
Previous 10,126 124.31%
Holding current value
$565,351
Previous $411,000 77.86%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$32.2 - $42.44 $405,333 - $534,234
12,588 Added 124.31%
22,714 $731,000
Q4 2023

Feb 14, 2024

SELL
$31.87 - $40.71 $66,098 - $84,432
-2,074 Reduced 17.0%
10,126 $411,000
Q3 2023

Nov 14, 2023

SELL
$34.17 - $42.98 $20,502 - $25,787
-600 Reduced 4.69%
12,200 $421,000
Q2 2023

Aug 14, 2023

BUY
$37.4 - $44.52 $33,660 - $40,068
900 Added 7.56%
12,800 $520,000
Q1 2023

May 15, 2023

BUY
$36.5 - $48.0 $434,350 - $571,200
11,900 New
11,900 $459,000

Others Institutions Holding GLPG

About GALAPAGOS NV


  • Ticker GLPG
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 65,835,500
  • Market Cap $1.64B
  • Description
  • Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative coliti...
More about GLPG
Track This Portfolio

Track Two Sigma Investments, LP Portfolio

Follow Two Sigma Investments, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.